News

Exercise for CIPN

Exercise for CIPN

Have you ever been watching TV and stumbled upon an advertisement promoting an 80s aerobics class—filled with bright workout outfits and groovy background music? For many, it brings back memories of decades past, when Jane Fonda and Arnold Schwarzenegger were iconic television figures; for others, like me, it exposes life before YouTube workout videos and …

Exercise for CIPN Read More »

Make Your Voice Heard: Join the Call to Action for PN Advocacy!

Help Advocate for Government Funding for Peripheral Neuropathy Research in 2025 Due to the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts on the Hill, and countless letters from PN patients like you, Congress designated peripheral neuropathy as a condition in the Peer Reviewed Medical Research Program (PRMRP) in the annual Defense Appropriations Act during fiscal …

Make Your Voice Heard: Join the Call to Action for PN Advocacy! Read More »

PN renewed in 2024 Defense Appropriations Bill

PN Renewed in 2024 Defense Appropriations Bill

On March 23, 2024, the Senate Committee on Appropriations approved, by a large bipartisan vote, the Senate version of the fiscal year 2024 Defense Appropriations Bill. As it has in the three previous years (FY21-23), the Committee renewed “peripheral neuropathy” (PN) as an eligible condition for receiving research grants from the Department of Defense’s Peer Reviewed …

PN Renewed in 2024 Defense Appropriations Bill Read More »

FY24 Peer Reviewed Medical Research Program

FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund for FY24. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) is sharing with you the FY24 funding mechanisms, award amounts, maximum direct costs and how to apply. FY24 …

FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available! Read More »

Chris advocates for peripheral neuropathy awareness

Chris F. is a resilient and dedicated individual residing in Madison, Wisconsin. Chris has led a remarkable life marked by a thriving business career and a strong commitment to family. Over three decades, he navigated the complexities of entrepreneurship, describing it as an exhilarating journey filled with challenges and triumphs. With 48 years of marriage …

Chris advocates for peripheral neuropathy awareness Read More »

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain

Principal Investigators Peter Grace, PhD, from MD Anderson Cancer Center, University of Texas, and Cobi Heijnen, PhD, from Rice University, were recently granted Investigator-Initiated Research Awards. Grace received funding totaling USD$3,064,079, and Heijnen received funding totaling USD$165,704. Peripheral Neuropathy Advocacy Grace and Heijnen’s awards were made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy …

Newly Funded Research: Targeting Local B Cells to Prevent Chronification of Neuropathic Pain Read More »

Importance of Peripheral Neuropathy

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy

Principal Investigator Shailly Jariwala, MS, PhD, of the Henry M. Jackson Foundation, was recently granted a Discovery Award totaling USD$319,151 for her research on a new therapy for peripheral neuropathy. Peripheral Neuropathy Advocacy Jariwala’s award was made possible through the Foundation for Peripheral Neuropathy’s (FPN) advocacy efforts with the Department of Defense’s CDMRP program. Advocacy …

Newly Funded Research: A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy Read More »

Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner

The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for …

Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner Read More »